PR Newswire Clinical TrialsOriginal article
Seegene предлагает комплексный подход к диагностике инфекций репродуктивного тракта в рамках клинического исследования Global Million Clinical Study (GMCS)
Data ReadoutpositiveSTAgora™Positive
AI Analysis
Summary
Seegene's Global Million Clinical Study analysis of 60,000 test results demonstrated that STI pathogens were detected in 82% of patients with positive HPV tests using the STAgora platform, supporting the value of comprehensive reproductive tract infection diagnostics.
Clinical Trial Data
Primary Endpoint
Met
Patients
60,000
Outcome Details
Analysis of ~60,000 test results over 42 months showed STI pathogens detected in 82% of patients with positive HPV test, demonstrating value of comprehensive diagnostic approach
Importance:5/10
Sentiment:
0.60
diagnosticsinfectious diseaseSTIHPVclinical studyreproductive health
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on July 29, 2026 6:00 AM